Hammerschmidt W - Search Results

1

HLA type-independent generation of antigen-specific T cells for adoptive immunotherapy.

Hammer MH, Meyer S, Brestrich G, Moosmann A, Kern F, Tesfa L, Babel N, Mittenzweig A, Rooney CM, Hammerschmidt W, Volk HD, Reinke P. Hammer MH, et al. Among authors: hammerschmidt w. Eur J Immunol. 2005 Jul;35(7):2250-8. doi: 10.1002/eji.200526230. Eur J Immunol. 2005. PMID: 15915543 Free article.

2

Selection of CMV-specific CD8+ and CD4+ T cells by mini-EBV-transformed B cell lines.

Wiesner M, Zentz C, Hammer MH, Cobbold M, Kern F, Kolb HJ, Hammerschmidt W, Zeidler R, Moosmann A. Wiesner M, et al. Among authors: hammerschmidt w. Eur J Immunol. 2005 Jul;35(7):2110-21. doi: 10.1002/eji.200425936. Eur J Immunol. 2005. PMID: 15971271 Free article.

3

Activated B cells mediate efficient expansion of rare antigen-specific T cells.

Zentz C, Wiesner M, Man S, Frankenberger B, Wollenberg B, Hillemanns P, Zeidler R, Hammerschmidt W, Moosmann A. Zentz C, et al. Among authors: hammerschmidt w. Hum Immunol. 2007 Feb;68(2):75-85. doi: 10.1016/j.humimm.2006.12.004. Epub 2007 Jan 8. Hum Immunol. 2007. PMID: 17321896

4

CMV-specific TCR-transgenic T cells for immunotherapy.

Schub A, Schuster IG, Hammerschmidt W, Moosmann A. Schub A, et al. Among authors: hammerschmidt w. J Immunol. 2009 Nov 15;183(10):6819-30. doi: 10.4049/jimmunol.0902233. Epub 2009 Oct 28. J Immunol. 2009. PMID: 19864595

5

Virus-specific T cells for therapy--approaches, problems, solutions.

Moosmann A, Hammerschmidt W, Kolb HJ. Moosmann A, et al. Among authors: hammerschmidt w. Eur J Cell Biol. 2012 Jan;91(1):97-101. doi: 10.1016/j.ejcb.2011.04.001. Epub 2011 Jun 2. Eur J Cell Biol. 2012. PMID: 21640430 Review.

6

B cells immortalized by a mini-Epstein-Barr virus encoding a foreign antigen efficiently reactivate specific cytotoxic T cells.

Moosmann A, Khan N, Cobbold M, Zentz C, Delecluse HJ, Hollweck G, Hislop AD, Blake NW, Croom-Carter D, Wollenberg B, Moss PA, Zeidler R, Rickinson AB, Hammerschmidt W. Moosmann A, et al. Among authors: hammerschmidt w. Blood. 2002 Sep 1;100(5):1755-64. Blood. 2002. PMID: 12176897 Free article.

7

Toll-like receptor agonists synergistically increase proliferation and activation of B cells by epstein-barr virus.

Iskra S, Kalla M, Delecluse HJ, Hammerschmidt W, Moosmann A. Iskra S, et al. Among authors: hammerschmidt w. J Virol. 2010 Apr;84(7):3612-23. doi: 10.1128/JVI.01400-09. Epub 2010 Jan 20. J Virol. 2010. PMID: 20089650 Free PMC article.

8

Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells.

Albanese M, Tagawa T, Bouvet M, Maliqi L, Lutter D, Hoser J, Hastreiter M, Hayes M, Sugden B, Martin L, Moosmann A, Hammerschmidt W. Albanese M, et al. Among authors: hammerschmidt w. Proc Natl Acad Sci U S A. 2016 Oct 18;113(42):E6467-E6475. doi: 10.1073/pnas.1605884113. Epub 2016 Oct 3. Proc Natl Acad Sci U S A. 2016. PMID: 27698133 Free PMC article.

9

Conditional immortalization of human B cells by CD40 ligation.

Wiesner M, Zentz C, Mayr C, Wimmer R, Hammerschmidt W, Zeidler R, Moosmann A. Wiesner M, et al. Among authors: hammerschmidt w. PLoS One. 2008 Jan 23;3(1):e1464. doi: 10.1371/journal.pone.0001464. PLoS One. 2008. PMID: 18213373 Free PMC article.

10

The EBV immunoevasins vIL-10 and BNLF2a protect newly infected B cells from immune recognition and elimination.

Jochum S, Moosmann A, Lang S, Hammerschmidt W, Zeidler R. Jochum S, et al. Among authors: hammerschmidt w. PLoS Pathog. 2012;8(5):e1002704. doi: 10.1371/journal.ppat.1002704. Epub 2012 May 17. PLoS Pathog. 2012. PMID: 22615564 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

153 results

Search Page